Teva Pharmaceutical (TEVA)

Teva Pharmaceutical (TEVA) Income Statement


Teva Pharmaceutical Income Statement

Last quarter (Q4 2023), Teva Pharmaceutical's total revenue was $4.46B, an increase of 14.78% from the same quarter last year. In Q4, Teva Pharmaceutical's net income was $1.57B. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 15.85B$ 15.85B$ 14.93B$ 15.88B$ 16.66B$ 16.89B
Cost of Revenue
$ 8.20B$ 8.20B$ 7.95B$ -8.28B$ 8.93B$ 9.35B
Gross Profit
$ 7.65B$ 7.65B$ 6.97B$ 7.59B$ 7.73B$ 7.54B
Operating Expense
$ 3.31B$ 2.29B$ -4.28B$ 5.88B$ 4.67B$ 4.79B
Operating Income
$ 2.38B$ 433.00M$ 2.69B$ 1.72B$ 3.06B$ 2.74B
Net Non Operating Interest Income Expense
$ -1.29B$ -1.03B$ -991.00M$ -1.06B$ -963.00M$ -877.00M
Other Income Expense
$ 104.00M$ 1.05B$ 4.76B$ -9.00M$ -6.50B$ -3.13B
Pretax Income
$ -624.00M$ -624.00M$ -3.06B$ 658.00M$ -4.41B$ -1.26B
Tax Provision
$ -7.00M$ -7.00M$ -638.00M$ 211.00M$ -168.00M$ -278.00M
Earnings From Equity Interest Net Of Tax
$ 2.00M$ 2.00M-$ 9.00M$ 138.00M$ -13.00M
Net Income Common Stockholders
$ 1.40B$ 3.66B$ -2.35B$ 416.00M$ -3.99B$ -999.00M
Basic EPS
$ -0.50$ -0.50$ -2.12$ 0.38$ -3.64$ -0.91
Diluted EPS
$ -0.49$ -0.50$ -2.12$ 0.38$ -3.64$ -0.91
Basic Average Shares
$ 4.48B$ 1.12B$ 1.11B$ 1.10B$ 1.09B$ 1.09B
Diluted Average Shares
$ 4.48B$ 1.12B$ 1.11B$ 1.11B$ 1.09B$ 1.09B
Dividend Per Share
----$ 0.00$ 0.00
Total Operating Income As Reported
Reported Normalized Basic E P S
-----$ 2.41
Reported Normalized Diluted E P S
-----$ 2.40
Rent Expense Supplemental
Total Expenses
$ 11.51B$ 10.49B$ 9.28B$ -2.40B$ 13.60B$ 14.14B
Net Income From Continuing And Discontinued Operation
$ -592.00M$ -559.00M$ -2.35B$ 416.00M$ -3.99B$ -999.00M
Normalized Income
$ 1.73B$ 2.09B$ 1.02B-$ 2.26B$ 1.38B
Interest Expense
----$ 963.00M$ 881.00M
$ 665.00M$ 405.00M$ -2.13B$ 1.72B$ -3.44B$ -384.00M
$ 1.82B$ 1.56B$ -827.00M$ 3.05B$ -1.89B$ 1.34B
Currency in USD

Teva Pharmaceutical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis